Literature DB >> 9732254

Dural tenting sutures in pediatric neurosurgery.

K R Winston1.   

Abstract

Dural tenting sutures were used on a selective basis in 329 consecutive cranial operations in children; 16 (4.8%) required dural tenting sutures for the control of epidural bleeding and 313 (95.2%) required no dural sutures. Dural tenting sutures were never placed for prophylaxis or to satisfy a routine. Reoperation for postoperative epidural hematoma was required in 1 child (0.3%) and that child was subsequently discovered to have hemophilia. The author concludes that there is no compelling evidence for the prophylactic use of dural tenting sutures in children.

Entities:  

Mesh:

Year:  1998        PMID: 9732254     DOI: 10.1159/000028656

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  3 in total

1.  Usefulness of an additional mattress suture for the extracranial drainage catheter.

Authors:  Dong Woong Eom; Jung Soo Kim; Kyoung Dong Jeon; Hoon Kim; Byeong Sam Choi
Journal:  J Korean Neurosurg Soc       Date:  2013-11-30

2.  Necessity of dural tenting sutures in modern neurosurgery: protocol for a systematic review.

Authors:  Łukasz Przepiórka; Przemysław Kunert; Jarosław Żyłkowski; Jan Fortuniak; Patrycja Larysz; Dariusz Szczepanek; Karol Wiśniewski; Dariusz Jaskólski; Piotr Ładziński; Radosław Rola; Tomasz Trojanowski; Andrzej Marchel
Journal:  BMJ Open       Date:  2019-02-19       Impact factor: 2.692

3.  Prophylactic use of dural tenting sutures in elective craniotomies in adults-is it necessary? A study protocol for a multicentre, investigator- and participant-blinded randomised, parallel-group, non-inferiority trial.

Authors:  Przemysław Kunert; Łukasz Przepiórka; Jan Fortuniak; Karol Wiśniewski; Ernest Jan Bobeff; Patrycja Larysz; Rafał Kruk; Bartłomiej Kulesza; Dariusz Szczepanek; Piotr Ładziński; Jarosław Żyłkowski; Sławomir Kujawski; Kamila Łabędzka; Dariusz Jaskólski; Radosław Rola; Tomasz Trojanowski; Andrzej Marchel
Journal:  Trials       Date:  2021-04-12       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.